| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1536 | 2015 |
| The effect of physical activity on cognitive function in patients with dementia: a meta-analysis of randomized control trials C Groot, AM Hooghiemstra, PGHM Raijmakers, BNM van Berckel, ... Ageing research reviews 25, 13-23, 2016 | 742 | 2016 |
| Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C] PK11195 positron emission tomography study BN Van Berckel, MG Bossong, R Boellaard, R Kloet, A Schuitemaker, ... Biological psychiatry 64 (9), 820-822, 2008 | 701 | 2008 |
| Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 629 | 2015 |
| The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features R Ossenkoppele, YAL Pijnenburg, DC Perry, BI Cohn-Sheehy, ... Brain 138 (9), 2732-2749, 2015 | 548 | 2015 |
| Δ9-tetrahydrocannabinol induces dopamine release in the human striatum MG Bossong, BN Van Berckel, R Boellaard, L Zuurman, RC Schuit, ... Neuropsychopharmacology 34 (3), 759-766, 2009 | 483 | 2009 |
| Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment MAA Binnewijzend, MM Schoonheim, E Sanz-Arigita, AM Wink, ... Neurobiology of aging 33 (9), 2018-2028, 2012 | 446 | 2012 |
| Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ... Brain 138 (5), 1327-1338, 2015 | 383 | 2015 |
| Optimizing patient care and research: the Amsterdam Dementia Cohort WM van der Flier, YAL Pijnenburg, N Prins, AW Lemstra, FH Bouwman, ... Journal of Alzheimer's disease 41 (1), 313-327, 2014 | 379 | 2014 |
| Blood–brain barrier P-glycoprotein function in Alzheimer's disease DME van Assema, M Lubberink, M Bauer, WM van der Flier, RC Schuit, ... Brain 135 (1), 181-189, 2012 | 338 | 2012 |
| Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity MAA Binnewijzend, JPA Kuijer, MR Benedictus, WM van der Flier, ... Radiology 267 (1), 221-230, 2013 | 314 | 2013 |
| Plasma amyloid as prescreener for the earliest A lzheimer pathological changes IMW Verberk, RE Slot, SCJ Verfaillie, H Heijst, ND Prins, ... Annals of neurology 84 (5), 648-658, 2018 | 303 | 2018 |
| SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0 DSW Djang, MJR Janssen, N Bohnen, J Booij, TA Henderson, K Herholz, ... Journal of Nuclear Medicine 53 (1), 154-163, 2012 | 278 | 2012 |
| Atrophy patterns in early clinical stages across distinct phenotypes of A lzheimer's disease R Ossenkoppele, BI Cohn‐Sheehy, R La Joie, JW Vogel, C Möller, ... Human brain mapping 36 (11), 4421-4437, 2015 | 237 | 2015 |
| Effect of age on functional P‐glycoprotein in the blood‐brain barrier measured by use of (R)‐[11C]verapamil and positron emission tomography R Toornvliet, BNM van Berckel, G Luurtsema, M Lubberink, AA Geldof, ... Clinical Pharmacology & Therapeutics 79 (6), 540-548, 2006 | 222 | 2006 |
| Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder E Geuze, BNM Van Berckel, AA Lammertsma, R Boellaard, CS De Kloet, ... Molecular psychiatry 13 (1), 74-83, 2008 | 217 | 2008 |
| Impact of molecular imaging on the diagnostic process in a memory clinic R Ossenkoppele, ND Prins, YAL Pijnenburg, AW Lemstra, ... Alzheimer's & dementia 9 (4), 414-421, 2013 | 216 | 2013 |
| Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease A Prestia, A Caroli, WM Van Der Flier, R Ossenkoppele, B Van Berckel, ... Neurology 80 (11), 1048-1056, 2013 | 212 | 2013 |
| Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding N Tolboom, WM van der Flier, M Yaqub, R Boellaard, NA Verwey, ... Journal of Nuclear Medicine 50 (9), 1464-1470, 2009 | 207 | 2009 |
| Microglial activation in Alzheimer's disease: an (R)-[11C] PK11195 positron emission tomography study A Schuitemaker, MA Kropholler, R Boellaard, WM van der Flier, RW Kloet, ... Neurobiology of aging 34 (1), 128-136, 2013 | 195 | 2013 |
Philip ScheltensProfessor of Neurology在 amsterdamumc.nl 的电子邮件经过验证
